These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
FORM 10-Q
|
[X]
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
For the quarterly period ended December 26, 2009
|
[ ]
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
For the transition period from ________ to ________.
|
Delaware
(State or Other Jurisdiction of Incorporation or Organization)
|
|
94-2896096
(I.R.S. Employer I. D. No.)
|
Large accelerated filer [x]
|
Accelerated filer [ ]
|
Non-accelerated filer [ ]
(Do not check if a smaller reporting company) |
Smaller reporting company [ ]
|
|
|
|
|
|
PART I - FINANCIAL INFORMATION
|
|
Page
|
|
|
|
Item 1. Financial Statements (unaudited)
|
|
|
|
|
|
Condensed Consolidated Balance Sheets as of December 26, 2009 and June 27, 2009
|
|
|
|
|
|
Condensed Consolidated Statements of Operations for the Three and Six Months Ended December 26, 2009 and December 27, 2008
|
|
|
|
|
|
Condensed Consolidated Statements of Cash Flows for the Six Months Ended December 26, 2009 and December 27, 2008
|
|
|
|
|
|
Notes to Condensed Consolidated Financial Statements
|
|
|
|
|
|
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
|
|
|
|
|
|
Item 3. Quantitative and Qualitative Disclosures About Market Risk
|
|
|
|
|
|
Item 4. Controls and Procedures
|
|
|
|
|
|
PART II - OTHER INFORMATION
|
|
|
|
|
|
Item 1. Legal Proceedings
|
|
|
|
|
|
Item 1A. Risk Factors
|
|
|
|
|
|
Item 2. Unregistered Sales of Equity Securities
|
|
|
|
|
|
Item 3. Defaults Upon Senior Securities
|
|
|
|
|
|
Item 4. Submission of Matters to a Vote of Shareholders
|
|
|
|
|
|
Item 5. Other Information
|
|
|
|
|
|
Item 6. Exhibits
|
|
|
|
|
|
SIGNATURES
|
|
|
December 26,
2009 |
|
June 27,
2009 |
||||
|
(in thousands)
|
||||||
ASSETS
|
|||||||
Current assets:
|
|
|
|
||||
Cash and cash equivalents
|
$
|
737,522
|
|
|
$
|
709,348
|
|
Short-term investments
|
101,038
|
|
|
204,055
|
|
||
Total cash, cash equivalents and short-term investments
|
838,560
|
|
|
913,403
|
|
||
Accounts receivable, net
|
281,122
|
|
|
207,807
|
|
||
Inventories
|
196,044
|
|
|
217,847
|
|
||
Deferred tax assets
|
188,867
|
|
|
211,879
|
|
||
Income tax refund receivable
|
432
|
|
|
13,072
|
|
||
Other current assets
|
26,535
|
|
|
20,943
|
|
||
Total current assets
|
1,531,560
|
|
|
1,584,951
|
|
||
Property, plant and equipment, net
|
1,341,832
|
|
|
1,366,052
|
|
||
Other assets
|
125,060
|
|
|
130,772
|
|
||
TOTAL ASSETS
|
$
|
2,998,452
|
|
|
$
|
3,081,775
|
|
|
|
|
|
||||
LIABILITIES AND STOCKHOLDERS' EQUITY
|
|||||||
Current liabilities:
|
|
|
|
||||
Accounts payable
|
$
|
69,255
|
|
|
$
|
70,087
|
|
Income taxes payable
|
2,501
|
|
|
2,140
|
|
||
Accrued salary and related expenses
|
129,366
|
|
|
141,334
|
|
||
Accrued expenses
|
38,043
|
|
|
38,455
|
|
||
Deferred income on shipments to distributors
|
18,227
|
|
|
16,760
|
|
||
Total current liabilities
|
257,392
|
|
|
268,776
|
|
||
Other liabilities
|
25,544
|
|
|
26,398
|
|
||
Income taxes payable
|
99,322
|
|
|
124,863
|
|
||
Deferred tax liabilities
|
71,061
|
|
|
67,273
|
|
||
Total liabilities
|
453,319
|
|
|
487,310
|
|
||
Commitments and contingencies (Note 11)
|
|
|
|
||||
Stockholders' equity
|
|
|
|
||||
Common stock and capital in excess of par value
|
305
|
|
|
21,511
|
|
||
Retained earnings
|
2,553,889
|
|
|
2,580,610
|
|
||
Accumulated other comprehensive loss
|
(9,061
|
)
|
|
(7,656
|
)
|
||
Total stockholders' equity
|
2,545,133
|
|
|
2,594,465
|
|
||
TOTAL LIABILITIES & STOCKHOLDERS' EQUITY
|
$
|
2,998,452
|
|
|
$
|
3,081,775
|
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||||||||
|
December 26,
2009 |
|
December 27,
2008 |
|
December 26,
2009 |
|
December 27,
2008 |
||||||||
|
(Amounts in thousands, except per share data)
|
||||||||||||||
|
|
|
|
|
|
|
|
||||||||
Net revenues
|
$
|
473,515
|
|
|
$
|
410,675
|
|
|
$
|
922,761
|
|
|
$
|
911,879
|
|
Cost of goods sold (1)
|
181,727
|
|
|
211,590
|
|
|
379,346
|
|
|
421,244
|
|
||||
Gross margin
|
291,788
|
|
|
199,085
|
|
|
543,415
|
|
|
490,635
|
|
||||
Operating expenses:
|
|
|
|
|
|
|
|
||||||||
Research and development (1)
|
118,367
|
|
|
144,283
|
|
|
235,060
|
|
|
283,198
|
|
||||
Selling, general and administrative (1)
|
61,308
|
|
|
64,124
|
|
|
116,298
|
|
|
104,367
|
|
||||
In process research & development
|
—
|
|
|
3,900
|
|
|
—
|
|
|
3,900
|
|
||||
Impairment of long-lived assets
|
—
|
|
|
43,769
|
|
|
8,291
|
|
|
51,112
|
|
||||
Severance and restructuring expenses
|
2,063
|
|
|
13,597
|
|
|
502
|
|
|
17,703
|
|
||||
Other operating expenses, net
|
921
|
|
|
10,252
|
|
|
(15,964
|
)
|
|
17,610
|
|
||||
Total operating expenses
|
182,659
|
|
|
279,925
|
|
|
344,187
|
|
|
477,890
|
|
||||
Operating income (loss)
|
109,129
|
|
|
(80,840
|
)
|
|
199,228
|
|
|
12,745
|
|
||||
Interest income and other, net
|
3,630
|
|
|
7,385
|
|
|
5,531
|
|
|
16,486
|
|
||||
Income (loss) before provision (benefit) for income taxes
|
112,759
|
|
|
(73,455
|
)
|
|
204,759
|
|
|
29,231
|
|
||||
Provision (benefit) for income taxes
|
54,124
|
|
|
(34,671
|
)
|
|
104,172
|
|
|
448
|
|
||||
Net income (loss)
|
$
|
58,635
|
|
|
$
|
(38,784
|
)
|
|
$
|
100,587
|
|
|
$
|
28,783
|
|
|
|
|
|
|
|
|
|
||||||||
Earnings (loss) per share:
|
|
|
|
|
|
|
|
||||||||
Basic
|
$
|
0.19
|
|
|
$
|
(0.12
|
)
|
|
$
|
0.33
|
|
|
$
|
0.09
|
|
Diluted
|
$
|
0.19
|
|
|
$
|
(0.12
|
)
|
|
$
|
0.32
|
|
|
$
|
0.09
|
|
|
|
|
|
|
|
|
|
||||||||
Shares used in the calculation of earnings (loss) per share:
|
|
|
|
|
|
|
|
||||||||
Basic
|
305,324
|
|
|
312,718
|
|
|
305,821
|
|
|
316,635
|
|
||||
Diluted
|
310,090
|
|
|
312,718
|
|
|
310,798
|
|
|
318,725
|
|
||||
|
|
|
|
|
|
|
|
||||||||
Dividends declared per share
|
$
|
0.200
|
|
|
$
|
0.200
|
|
|
$
|
0.400
|
|
|
$
|
0.400
|
|
|
|
|
|
|
|
|
|
||||||||
(1) Includes stock-based compensation charges as follows:
|
|||||||||||||||
Cost of goods sold
|
$
|
5,265
|
|
|
$
|
30,834
|
|
|
$
|
10,726
|
|
|
$
|
42,754
|
|
Research and development
|
14,650
|
|
|
33,432
|
|
|
31,391
|
|
|
52,851
|
|
||||
Selling, general and administrative
|
7,018
|
|
|
19,672
|
|
|
11,281
|
|
|
25,894
|
|
||||
|
$
|
26,933
|
|
|
$
|
83,938
|
|
|
$
|
53,398
|
|
|
$
|
121,499
|
|
|
Six Months Ended
|
||||||
|
December 26,
2009 |
|
December 27,
2008 |
||||
|
(in thousands)
|
||||||
Cash flows from operating activities:
|
|
|
|
||||
Net income
|
$
|
100,587
|
|
|
$
|
28,783
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
|
||||
Stock based compensation
|
53,398
|
|
|
121,498
|
|
||
Depreciation and amortization
|
76,328
|
|
|
97,674
|
|
||
Deferred taxes
|
26,403
|
|
|
168,574
|
|
||
Tax benefit (shortfall) related to stock based compensation plans
|
(10,143
|
)
|
|
(149,082
|
)
|
||
Excess tax benefit related to stock based compensation
|
(3,898
|
)
|
|
(461
|
)
|
||
In-process research & development
|
—
|
|
|
3,900
|
|
||
Impairment of long-lived assets
|
8,291
|
|
|
51,112
|
|
||
Loss on sale of property, plant and equipment
|
1,092
|
|
|
1,887
|
|
||
Loss (gain) from sale of equity investments
|
149
|
|
|
(529
|
)
|
||
Changes in assets and liabilities:
|
|
|
|
||||
Accounts receivable
|
(73,315
|
)
|
|
58,936
|
|
||
Inventories
|
19,003
|
|
|
14,209
|
|
||
Other current assets
|
8,895
|
|
|
(60,726
|
)
|
||
Accounts payable
|
(643
|
)
|
|
(124
|
)
|
||
Income taxes payable
|
(26,075
|
)
|
|
2,481
|
|
||
Deferred income on shipments to distributors
|
1,467
|
|
|
(850
|
)
|
||
Accrued liabilities - goodwill payments above settlement date fair value
|
(993
|
)
|
|
(37,041
|
)
|
||
All other accrued liabilities
|
(11,070
|
)
|
|
(70,762
|
)
|
||
Net cash provided by operating activities
|
169,476
|
|
|
229,479
|
|
||
Cash flows from investing activities:
|
|
|
|
||||
Purchase of property, plant and equipment
|
(54,752
|
)
|
|
(67,535
|
)
|
||
Proceeds from sale of property, plant, and equipment
|
665
|
|
|
947
|
|
||
Other non-current assets
|
1,737
|
|
|
(1,246
|
)
|
||
Acquisitions
|
(4,000
|
)
|
|
(30,310
|
)
|
||
Purchases of available-for-sale securities
|
—
|
|
|
(2,740
|
)
|
||
Proceeds from sales/maturities of available-for-sale securities
|
100,233
|
|
|
4,675
|
|
||
Net cash provided by (used in) investing activities
|
43,883
|
|
|
(96,209
|
)
|
||
Cash flows from financing activities:
|
|
|
|
||||
Excess tax benefit related to stock based compensation
|
3,898
|
|
|
461
|
|
||
Mortgage liability
|
(20
|
)
|
|
(20
|
)
|
||
Payouts under the RSU loan program
|
—
|
|
|
(35,578
|
)
|
||
Proceeds from derivative litigation settlement
|
2,460
|
|
|
—
|
|
||
Repayment of notes payable
|
—
|
|
|
(2,673
|
)
|
||
Issuance of common stock
|
(14,970
|
)
|
|
(15,174
|
)
|
||
Repurchase of common stock
|
(64,470
|
)
|
|
(235,131
|
)
|
||
Issuance of common stock under employee stock purchase plan
|
10,703
|
|
|
—
|
|
||
Dividends paid
|
(122,394
|
)
|
|
(126,414
|
)
|
||
Settlements of equity instrustments
|
(392
|
)
|
|
(13,660
|
)
|
||
Net cash used in financing activities
|
(185,185
|
)
|
|
(428,189
|
)
|
||
Net increase (decrease) in cash and cash equivalents
|
28,174
|
|
|
(294,919
|
)
|
||
Cash and cash equivalents:
|
|
|
|
||||
Beginning of period
|
709,348
|
|
|
1,013,119
|
|
||
End of period
|
$
|
737,522
|
|
|
$
|
718,200
|
|
Supplemental disclosures of cash flow information:
|
|
|
|
||||
Cash paid, net during the period for income taxes
|
$
|
101,335
|
|
|
$
|
37,160
|
|
Noncash investing and financing activities:
|
|
|
|
||||
Accounts payable related to property, plant, and equipment purchases
|
$
|
15,523
|
|
|
$
|
22,068
|
|
|
December 26,
2009 |
|
June 27,
2009 |
||||
Inventories:
|
(in thousands)
|
||||||
Raw materials
|
$
|
16,443
|
|
|
$
|
14,235
|
|
Work-in-process
|
133,476
|
|
|
166,970
|
|
||
Finished goods
|
46,125
|
|
|
36,642
|
|
||
|
$
|
196,044
|
|
|
$
|
217,847
|
|
|
December 26,
2009 |
|
June 27,
2009 |
||||
Other Assets:
|
(In thousands)
|
||||||
Deferred tax assets
|
$
|
5,914
|
|
|
$
|
5,914
|
|
Intangible assets, net (Note 16)
|
69,009
|
|
|
76,295
|
|
||
Goodwill (Note 16)
|
29,586
|
|
|
26,710
|
|
||
Other
|
20,551
|
|
|
21,853
|
|
||
|
$
|
125,060
|
|
|
$
|
130,772
|
|
|
|
|
Fair Value Measurements Using
|
||||||||||||
|
Balance as of
December 26, 2009 |
|
Quoted Prices in
Active Markets for Identical Instruments (Level 1) |
|
Significant Other
Observable Inputs (Level 2) |
|
Significant
Unobservable Inputs (Level 3) |
||||||||
|
(in thousands)
|
||||||||||||||
Assets:
|
|
|
|
|
|
|
|
||||||||
Money market funds (1)
|
$
|
674,203
|
|
|
$
|
672,081
|
|
|
$
|
2,122
|
|
|
$
|
—
|
|
U.S. Treasury Notes (2)
|
101,038
|
|
|
101,038
|
|
|
—
|
|
|
—
|
|
||||
Foreign currency derivative contracts, (net)
|
468
|
|
|
—
|
|
|
468
|
|
|
—
|
|
||||
Total assets measured at fair value
|
$
|
775,709
|
|
|
$
|
773,119
|
|
|
$
|
2,590
|
|
|
$
|
—
|
|
(1)
|
Included in cash and cash equivalents in the accompanying Condensed Consolidated Balance Sheets as of December 26, 2009
|
(2)
|
Included in short-term investments in the accompanying Condensed Consolidated Balance Sheets as of December 26, 2009
|
|
|
|
Fair Value Measurements Using
|
||||||||||||
|
Balance as of
December 26, 2009 |
|
Quoted Prices in
Active Markets for
Identical Instruments
(Level 1)
|
|
Significant Other
Observable Inputs (Level 2) |
|
Significant
Unobservable
Inputs
(Level 3)
|
||||||||
|
(in thousands)
|
||||||||||||||
Assets:
|
|
|
|
|
|
|
|
||||||||
Assets Held for Sale (1)
|
$
|
4,562
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
4,562
|
|
Total assets measured at fair value
|
$
|
4,562
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
4,562
|
|
(1)
|
Included in Other Assets in the accompanying Condensed Consolidated Balance Sheets as of December 26, 2009
|
|
Total Losses for
|
||||||
|
Three Months Ended
|
|
Six Months Ended
|
||||
|
December 26, 2009
|
|
December 26, 2009
|
||||
|
(in thousands)
|
||||||
Impairment of long-lived assets designated as held for sale during the period
|
$
|
—
|
|
|
$
|
(8,291
|
)
|
Total losses recorded for non-recurring measurements
|
$
|
—
|
|
|
$
|
(8,291
|
)
|
|
|
Fair Value Derivative Instrument
|
||||||||
Derivatives not designed as hedging instruments under generally accepted accounting principles
|
|
Balance sheet location
|
|
Fair Value
December 26, 2009 |
|
Fair Value
June 27, 2009 |
||||
|
|
|
|
(in thousands)
|
||||||
Foreign exchange contracts
|
|
Accounts receivable, net
|
|
$
|
468
|
|
|
$
|
(480
|
)
|
Total
|
|
|
|
$
|
468
|
|
|
$
|
(480
|
)
|
Derivatives not designated as
hedging instruments under generally accepted accounting principles |
|
Location of Gain or
(Loss) Recognized in Income on Derivatives |
|
Amount of Gain or (Loss) Recognized in
Income on Derivative |
||||||||||||||
|
|
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||||||||
|
|
|
|
December 26,
2009 |
|
December 27,
2008 |
|
December 26,
2009 |
|
December 27,
2008 |
||||||||
|
|
|
|
(in thousands)
|
||||||||||||||
Foreign exchange contracts
|
|
Interest income and other, net
|
|
$
|
1,018
|
|
|
$
|
(2,309
|
)
|
|
$
|
(532
|
)
|
|
$
|
(1,884
|
)
|
Total
|
|
|
|
$
|
1,018
|
|
|
$
|
(2,309
|
)
|
|
$
|
(532
|
)
|
|
$
|
(1,884
|
)
|
In United States Dollars
|
|
December 26, 2009
|
|
June 27, 2009
|
||||
|
|
(in thousands)
|
||||||
Euro
|
|
$
|
27,187
|
|
|
$
|
28,054
|
|
Japanese Yen
|
|
37,105
|
|
|
36,533
|
|
||
British Pound
|
|
10,500
|
|
|
6,045
|
|
||
Other
|
|
18,221
|
|
|
6,703
|
|
||
Total
|
|
$
|
93,013
|
|
|
$
|
77,335
|
|
Stock-based compensation expense by type of award
|
|||||||||||||||
|
|
|
|
||||||||||||
|
Three Months Ended
|
|
Six Months Ended
|
||||||||||||
|
December 26,
2009 |
|
December 27,
2008 |
|
December 26,
2009 |
|
December 27,
2008 |
||||||||
|
(in thousands)
|
||||||||||||||
Cost of goods sold
|
|
|
|
|
|
|
|
||||||||
Stock options
|
$
|
401
|
|
|
$
|
23,785
|
|
|
$
|
2,416
|
|
|
$
|
29,900
|
|
Restricted stock units
|
4,730
|
|
|
7,049
|
|
|
7,808
|
|
|
12,854
|
|
||||
Employee stock purchase plan
|
134
|
|
|
—
|
|
|
502
|
|
|
—
|
|
||||
|
$
|
5,265
|
|
|
$
|
30,834
|
|
|
$
|
10,726
|
|
|
$
|
42,754
|
|
Research and development expense
|
|
|
|
|
|
|
|
||||||||
Stock options
|
$
|
3,625
|
|
|
$
|
21,978
|
|
|
$
|
7,756
|
|
|
$
|
29,713
|
|
Restricted stock units
|
9,821
|
|
|
11,454
|
|
|
21,018
|
|
|
23,138
|
|
||||
Employee stock purchase plan
|
1,204
|
|
|
—
|
|
|
2,617
|
|
|
—
|
|
||||
|
$
|
14,650
|
|
|
$
|
33,432
|
|
|
$
|
31,391
|
|
|
$
|
52,851
|
|
Selling, general and administrative expense
|
|
|
|
|
|
|
|
||||||||
Stock options
|
$
|
2,273
|
|
|
$
|
15,336
|
|
|
$
|
4,022
|
|
|
$
|
17,746
|
|
Restricted stock units
|
4,454
|
|
|
4,336
|
|
|
6,832
|
|
|
8,148
|
|
||||
Employee stock purchase plan
|
291
|
|
|
—
|
|
|
427
|
|
|
—
|
|
||||
|
$
|
7,018
|
|
|
$
|
19,672
|
|
|
$
|
11,281
|
|
|
$
|
25,894
|
|
Total stock-based compensation expense
|
|
|
|
|
|
|
|
||||||||
Stock options
|
$
|
6,299
|
|
|
$
|
61,099
|
|
|
$
|
14,194
|
|
|
$
|
77,359
|
|
Restricted stock units
|
19,005
|
|
|
22,839
|
|
|
35,658
|
|
|
44,140
|
|
||||
Employee stock purchase plan
|
1,629
|
|
|
—
|
|
|
3,546
|
|
|
—
|
|
||||
Pre-tax stock-based compensation expense
|
26,933
|
|
|
83,938
|
|
|
53,398
|
|
|
121,499
|
|
||||
Less: income tax effect
|
9,061
|
|
|
29,175
|
|
|
17,078
|
|
|
41,974
|
|
||||
Net stock-based compensation expense
|
$
|
17,872
|
|
|
$
|
54,763
|
|
|
$
|
36,320
|
|
|
$
|
79,525
|
|
|
Stock Option Plan
|
||||||||||
|
Three Months Ended
|
|
Six Months Ended
|
||||||||
|
December 26,
2009 |
|
December 27,
2008 |
|
December 26,
2009 |
|
December 27,
2008 |
||||
Expected holding period (in years)
|
5.2
|
|
|
6.3
|
|
|
5.2
|
|
|
6.3
|
|
Risk-free interest rate
|
2.3
|
%
|
|
2.9
|
%
|
|
2.3
|
%
|
|
2.9
|
%
|
Expected stock price volatility
|
37.8
|
%
|
|
40.0
|
%
|
|
37.8
|
%
|
|
40.0
|
%
|
Dividend yield
|
4.5
|
%
|
|
4.1
|
%
|
|
4.5
|
%
|
|
4.0
|
%
|
|
ESP Plan
|
||||||||||
|
Three Months Ended
|
|
Six Months Ended
|
||||||||
|
December 26,
2009 |
|
December 27,
2008 |
|
December 26,
2009 |
|
December 27,
2008 |
||||
Expected holding period (in years)
|
0.5
|
|
|
—
|
|
|
0.5
|
|
|
—
|
|
Risk-free interest rate
|
0.15
|
%
|
|
—
|
%
|
|
0.15
|
%
|
|
—
|
%
|
Expected stock price volatility
|
34.35
|
%
|
|
—
|
%
|
|
34.35
|
%
|
|
—
|
%
|
Dividend yield
|
4.5
|
%
|
|
—
|
%
|
|
4.5
|
%
|
|
—
|
%
|
|
Number of
Shares
|
|
Weighted Average
Exercise Price
|
|
Weighted
Average Remaining Contractual Term (in Years) |
|
Aggregate
Intrinsic
Value(1)
|
||||||
Balance at June 28, 2009
|
29,599,916
|
|
|
$
|
28.83
|
|
|
|
|
|
|||
Options Granted
|
3,320,438
|
|
|
18.01
|
|
|
|
|
|
||||
Options Exercised
|
(7,843
|
)
|
|
12.82
|
|
|
|
|
|
||||
Options Cancelled
|
(2,813,253
|
)
|
|
31.04
|
|
|
|
|
|
||||
Balance at December 26, 2009
|
30,099,258
|
|
|
$
|
27.48
|
|
|
4.6
|
|
|
$
|
62,301,756
|
|
Exercisable, December 26, 2009
|
15,909,555
|
|
|
$
|
34.83
|
|
|
3.3
|
|
|
$
|
1,996,222
|
|
Vested and expected to vest, December 26, 2009
|
29,024,918
|
|
|
$
|
27.88
|
|
|
4.5
|
|
|
$
|
57,515,018
|
|
(1)
|
Aggregate intrinsic value represents the difference between the exercise price and the closing price per share of the Company's common stock on December 24, 2009, the last business day proceeding the fiscal quarter-end multiplied by the number of options outstanding, exercisable or vested and expected to vest as of December 26, 2009.
|
|
Number of
Shares
|
|
Weighted Average
Remaining Contractual Term (in Years) |
|
Aggregate Intrinsic
Value(1)
|
||||
Balance at June 28, 2009
|
11,867,329
|
|
|
|
|
|
|||
Restricted stock units granted
|
3,482,991
|
|
|
|
|
|
|||
Restricted stock units released
|
(2,489,723
|
)
|
|
|
|
|
|||
Restricted stock units cancelled
|
(294,570
|
)
|
|
|
|
|
|||
Balance at December 26, 2009
|
12,566,027
|
|
|
1.7
|
|
|
$
|
252,980,776
|
|
Vested and expected to vest, December 26, 2009
|
11,480,867
|
|
|
1.7
|
|
|
$
|
231,224,648
|
|
(1)
|
Aggregate intrinsic value for RSUs represents the closing price per share of the Company's common stock on December 24, 2009, the last business day preceding the fiscal quarter-end multiplied by the number of RSUs outstanding or expected to vest as of December 26, 2009.
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||||||||
|
December 26,
2009 |
|
December 27,
2008 |
|
December 26,
2009 |
|
December 27,
2008 |
||||||||
|
(Amounts in thousands, except per share data)
|
||||||||||||||
Numerator for basic earnings (loss) per share and diluted earnings (loss) per share
|
|
|
|
|
|
|
|
||||||||
Net income (loss)
|
$
|
58,635
|
|
|
$
|
(38,784
|
)
|
|
$
|
100,587
|
|
|
$
|
28,783
|
|
|
|
|
|
|
|
|
|
||||||||
Denominator for basic earnings (loss) per share
|
305,324
|
|
|
312,718
|
|
|
305,821
|
|
|
316,635
|
|
||||
Effect of dilutive securities:
|
|
|
|
|
|
|
|
||||||||
Stock options, ESPP and RSUs
|
4,766
|
|
|
—
|
|
|
4,977
|
|
|
2,090
|
|
||||
Denominator for diluted earnings (loss) per share
|
310,090
|
|
|
312,718
|
|
|
310,798
|
|
|
318,725
|
|
||||
Earnings (loss) per share:
|
|
|
|
|
|
|
|
||||||||
Basic
|
$
|
0.19
|
|
|
$
|
(0.12
|
)
|
|
$
|
0.33
|
|
|
$
|
0.09
|
|
Diluted
|
$
|
0.19
|
|
|
$
|
(0.12
|
)
|
|
$
|
0.32
|
|
|
$
|
0.09
|
|
|
|
the nature of products and services;
|
|||
|
|
the nature of the production processes;
|
|||
|
|
the type or class of customer for their products and services; and
|
|||
|
|
the methods used to distribute their products or provide their services.
|
|
|
the sale of analog and mixed signal integrated circuits is the primary source of revenue for each of the Company's fourteen operating segments;
|
|||
|
|
the integrated circuits sold by each of the Company's operating segments are manufactured using similar semiconductor manufacturing processes;
|
|||
|
|
the integrated circuits marketed by each of the Company's operating segments are sold to the same types of customers; and
|
|||
|
|
all of the Company's integrated circuits are sold through a centralized sales force and common wholesale distributors.
|
|||
|
|
|
|
|
|
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||||||||
|
|
December 26,
2009 |
|
December 27,
2008 |
|
December 26,
2009 |
|
December 27,
2008 |
||||||||
|
|
(in thousands)
|
||||||||||||||
United States (1)
|
|
$
|
70,158
|
|
|
$
|
75,602
|
|
|
$
|
139,125
|
|
|
$
|
163,277
|
|
China
|
|
159,839
|
|
|
118,931
|
|
|
301,260
|
|
|
282,897
|
|
||||
Japan
|
|
30,713
|
|
|
33,498
|
|
|
65,123
|
|
|
71,357
|
|
||||
Korea
|
|
74,270
|
|
|
53,227
|
|
|
156,785
|
|
|
107,742
|
|
||||
Rest of Asia
|
|
54,747
|
|
|
45,763
|
|
|
106,476
|
|
|
101,177
|
|
||||
Europe
|
|
65,182
|
|
|
73,272
|
|
|
126,070
|
|
|
163,927
|
|
||||
Rest of World
|
|
18,606
|
|
|
10,382
|
|
|
27,922
|
|
|
21,502
|
|
||||
|
|
$
|
473,515
|
|
|
$
|
410,675
|
|
|
$
|
922,761
|
|
|
$
|
911,879
|
|
(1)
|
The Company previously included $23.9 million and $47.1 million of Korean revenues in United States revenues during the three and six months ended December 27, 2008.
|
|
December 26,
2009 |
|
June 27,
2009 |
||||
|
(in thousands)
|
||||||
United States
|
$
|
1,007,921
|
|
|
$
|
1,016,116
|
|
Philippines
|
227,202
|
|
|
234,004
|
|
||
Thailand
|
98,878
|
|
|
108,898
|
|
||
Rest of World
|
7,831
|
|
|
7,034
|
|
||
|
$
|
1,341,832
|
|
|
$
|
1,366,052
|
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||||||||
|
December 26,
2009 |
|
December 27,
2008 |
|
December 26,
2009 |
|
December 27,
2008 |
||||||||
|
(in thousands)
|
||||||||||||||
Net income (loss), as reported
|
$
|
58,635
|
|
|
$
|
(38,784
|
)
|
|
$
|
100,587
|
|
|
$
|
28,783
|
|
Change in unrealized (losses) gains on investments, net of tax benefits (expenses) of $135, $(672), $348 and $(1202), respectively
|
(237
|
)
|
|
1,184
|
|
|
(608
|
)
|
|
2,108
|
|
||||
Deferred tax on unrealized exchange (losses) gains on intercompany receivables
|
(531
|
)
|
|
859
|
|
|
(959
|
)
|
|
1,239
|
|
||||
Actuarial gains on post-retirement benefits, net of tax (expense) benefit of $(29), $0, $(58) and $0, respectively
|
52
|
|
|
—
|
|
|
104
|
|
|
—
|
|
||||
Total comprehensive income (loss)
|
$
|
57,919
|
|
|
$
|
(36,741
|
)
|
|
$
|
99,124
|
|
|
$
|
32,130
|
|
|
Six Months Ended
|
||||||||||
|
December 26, 2009
|
||||||||||
|
(in thousands)
|
||||||||||
|
Severance and
Benefits |
|
Other Exit
Costs |
|
Total
|
||||||
Balance, June 27, 2009
|
$
|
7,694
|
|
|
$
|
—
|
|
|
$
|
7,694
|
|
Restructuring provision
|
2,996
|
|
|
1,321
|
|
|
4,317
|
|
|||
Cash payments
|
(2,884
|
)
|
|
(1,321
|
)
|
|
(4,205
|
)
|
|||
Change in estimate
|
(3,815
|
)
|
|
—
|
|
|
(3,815
|
)
|
|||
Balance, December 26, 2009
|
$
|
3,991
|
|
|
$
|
—
|
|
|
$
|
3,991
|
|
|
Goodwill
|
||
Balance at June 27, 2009
|
$
|
26,710
|
|
New Acquisition
|
2,900
|
|
|
Adjustments
|
(24
|
)
|
|
Balance at December 26, 2009
|
$
|
29,586
|
|
Asset
|
|
Life
|
Intellectual Property
|
|
5-10 years
|
Customer Relationships
|
|
5-10 years
|
Tradename
|
|
3 years
|
Backlog
|
|
1 year
|
|
December 26, 2009
|
||||||||||
|
Original
Cost
|
|
Accumulated
Amortization
|
|
Net
|
||||||
|
(in thousands)
|
||||||||||
Intellectual property *
|
$
|
63,526
|
|
|
$
|
29,071
|
|
|
$
|
34,455
|
|
Customer relationships
|
42,330
|
|
|
8,019
|
|
|
34,311
|
|
|||
Tradename
|
400
|
|
|
156
|
|
|
244
|
|
|||
Backlog
|
200
|
|
|
200
|
|
|
—
|
|
|||
Total intangible assets
|
$
|
106,456
|
|
|
$
|
37,446
|
|
|
$
|
69,010
|
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||||||||
|
December 26,
2009 |
|
December 27,
2008 |
|
December 26,
2009 |
|
December 27,
2008 |
||||||||
|
(in thousands)
|
||||||||||||||
Intellectual property
|
$
|
2,699
|
|
|
$
|
2,261
|
|
|
$
|
5,394
|
|
|
$
|
4,032
|
|
Customer relationships
|
1,413
|
|
|
696
|
|
|
2,823
|
|
|
1,252
|
|
||||
Tradename
|
33
|
|
|
22
|
|
|
68
|
|
|
22
|
|
||||
Backlog
|
50
|
|
|
—
|
|
|
100
|
|
|
—
|
|
||||
Total amortization expense
|
$
|
4,195
|
|
|
$
|
2,979
|
|
|
$
|
8,385
|
|
|
$
|
5,306
|
|
Fiscal Year
|
|
Amount
|
||
|
|
(in thousands)
|
||
Remaining six months of 2010
|
|
$
|
8,279
|
|
2011
|
|
15,893
|
|
|
2012
|
|
15,069
|
|
|
2013
|
|
11,234
|
|
|
2014
|
|
6,819
|
|
|
Thereafter
|
|
10,617
|
|
|
Total *
|
|
$
|
67,911
|
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||||
|
December 26,
2009 |
|
December 27,
2008 |
|
December 26,
2009 |
|
December 27,
2008 |
||||
|
(in thousands)
|
||||||||||
Net revenues
|
100.0
|
%
|
|
100.0
|
%
|
|
100.0
|
%
|
|
100.0
|
%
|
Cost of goods sold
|
38.4
|
%
|
|
51.5
|
%
|
|
41.1
|
%
|
|
46.2
|
%
|
Gross margin
|
61.6
|
%
|
|
48.5
|
%
|
|
58.9
|
%
|
|
53.8
|
%
|
Operating expenses:
|
|
|
|
|
|
|
|
||||
Research and development
|
25.0
|
%
|
|
35.1
|
%
|
|
25.5
|
%
|
|
31.1
|
%
|
Selling, general and administrative
|
12.9
|
%
|
|
15.6
|
%
|
|
12.6
|
%
|
|
11.4
|
%
|
In-process research and development
|
—
|
%
|
|
0.9
|
%
|
|
—
|
%
|
|
0.4
|
%
|
Impairment of long-lived assets
|
—
|
%
|
|
10.7
|
%
|
|
0.9
|
%
|
|
5.6
|
%
|
Severance and restructuring expenses
|
0.4
|
%
|
|
3.3
|
%
|
|
0.1
|
%
|
|
1.9
|
%
|
Other operating expenses (recoveries), net
|
0.2
|
%
|
|
2.5
|
%
|
|
(1.7
|
)%
|
|
1.9
|
%
|
Total operating expenses
|
38.5
|
%
|
|
68.2
|
%
|
|
37.4
|
%
|
|
52.3
|
%
|
Operating income (loss)
|
23.1
|
%
|
|
(19.7
|
)%
|
|
21.5
|
%
|
|
1.5
|
%
|
Interest income and other, net
|
0.8
|
%
|
|
1.8
|
%
|
|
0.6
|
%
|
|
1.8
|
%
|
Income (loss) before provision for income taxes
|
23.9
|
%
|
|
(17.9
|
)%
|
|
22.1
|
%
|
|
3.3
|
%
|
Provision (benefit) for income taxes
|
11.4
|
%
|
|
(8.4
|
)%
|
|
11.3
|
%
|
|
—
|
%
|
Net income (loss)
|
12.5
|
%
|
|
(9.4
|
)%
|
|
10.8
|
%
|
|
3.3
|
%
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||||
|
December 26,
2009 |
|
December 27,
2008 |
|
December 26,
2009 |
|
December 27,
2008 |
||||
|
(in thousands)
|
||||||||||
Cost of goods sold
|
1.1
|
%
|
|
7.5
|
%
|
|
1.2
|
%
|
|
4.7
|
%
|
Research and development
|
3.1
|
%
|
|
8.1
|
%
|
|
3.4
|
%
|
|
5.8
|
%
|
Selling, general and adminstrative
|
1.5
|
%
|
|
4.8
|
%
|
|
1.2
|
%
|
|
2.8
|
%
|
|
5.7
|
%
|
|
20.4
|
%
|
|
5.8
|
%
|
|
13.3
|
%
|
Stock-based compensation expense by type of award
|
|||||||||||||||
|
|
|
|
||||||||||||
|
Three Months Ended
|
|
Six Months Ended
|
||||||||||||
|
December 26,
2009 |
|
December 27,
2008 |
|
December 26,
2009 |
|
December 27,
2008 |
||||||||
|
(in thousands)
|
||||||||||||||
Cost of goods sold
|
|
|
|
|
|
|
|
||||||||
Stock options
|
$
|
401
|
|
|
$
|
23,785
|
|
|
$
|
2,416
|
|
|
$
|
29,900
|
|
Restricted stock units
|
4,730
|
|
|
7,049
|
|
|
7,808
|
|
|
12,854
|
|
||||
Employee stock purchase plan
|
134
|
|
|
—
|
|
|
502
|
|
|
—
|
|
||||
|
$
|
5,265
|
|
|
$
|
30,834
|
|
|
$
|
10,726
|
|
|
$
|
42,754
|
|
Research and development expense
|
|
|
|
|
|
|
|
||||||||
Stock options
|
$
|
3,625
|
|
|
21,978
|
|
|
$
|
7,756
|
|
|
$
|
29,713
|
|
|
Restricted stock units
|
9,821
|
|
|
11,454
|
|
|
21,018
|
|
|
23,138
|
|
||||
Employee stock purchase plan
|
1,204
|
|
|
—
|
|
|
2,617
|
|
|
—
|
|
||||
|
$
|
14,650
|
|
|
$
|
33,432
|
|
|
$
|
31,391
|
|
|
$
|
52,851
|
|
Selling, general and administrative expense
|
|
|
|
|
|
|
|
||||||||
Stock options
|
$
|
2,273
|
|
|
$
|
15,336
|
|
|
$
|
4,022
|
|
|
$
|
17,746
|
|
Restricted stock units
|
4,454
|
|
|
4,336
|
|
|
6,832
|
|
|
8,148
|
|
||||
Employee stock purchase plan
|
291
|
|
|
—
|
|
|
427
|
|
|
—
|
|
||||
|
$
|
7,018
|
|
|
$
|
19,672
|
|
|
$
|
11,281
|
|
|
$
|
25,894
|
|
Total stock-based compensation expense
|
|
|
|
|
|
|
|
||||||||
Stock options
|
$
|
6,299
|
|
|
$
|
61,099
|
|
|
$
|
14,194
|
|
|
$
|
77,359
|
|
Restricted stock units
|
19,005
|
|
|
22,839
|
|
|
35,658
|
|
|
44,140
|
|
||||
Employee stock purchase plan
|
1,629
|
|
|
—
|
|
|
3,546
|
|
|
—
|
|
||||
Pre-tax stock-based compensation expense
|
26,933
|
|
|
83,938
|
|
|
53,398
|
|
|
121,499
|
|
||||
Less: income tax effect
|
9,061
|
|
|
29,175
|
|
|
17,078
|
|
|
41,974
|
|
||||
Net stock-based compensation expense
|
$
|
17,872
|
|
|
$
|
54,763
|
|
|
$
|
36,320
|
|
|
$
|
79,525
|
|
|
Three Months Ended
|
|
Six months Ended
|
||||||||||||
|
December 26,
2009 |
|
December 27,
2008 |
|
December 26,
2009 |
|
December 27,
2008 |
||||||||
|
(in thousands)
|
||||||||||||||
Legal and accounting expenses
|
$
|
2,735
|
|
|
$
|
9,585
|
|
|
$
|
8,477
|
|
|
$
|
20,874
|
|
Payroll tax and related adjustments
|
(1,814
|
)
|
|
331
|
|
|
(8,043
|
)
|
|
(5,050
|
)
|
||||
Termination benefits
|
—
|
|
|
(2,402
|
)
|
|
—
|
|
|
(2,402
|
)
|
||||
Derivative litigation settlement
|
—
|
|
|
—
|
|
|
(16,419
|
)
|
|
—
|
|
||||
Other
|
—
|
|
|
2,739
|
|
|
21
|
|
|
4,189
|
|
||||
Total
|
$
|
921
|
|
|
$
|
10,253
|
|
|
$
|
(15,964
|
)
|
|
$
|
17,611
|
|
|
December 26,
2009 |
|
June 27,
2009 |
||||
|
(in thousands)
|
||||||
Cash and cash equivalents
|
$
|
737,522
|
|
|
$
|
709,348
|
|
Short-term investments
|
101,038
|
|
|
204,055
|
|
||
Total cash, cash equivalents and investments
|
$
|
838,560
|
|
|
$
|
913,403
|
|
|
Six months Ended
|
||||||
|
December 26,
2009 |
|
December 27,
2008 |
||||
|
(in thousands)
|
||||||
Net cash provided by operating activities
|
$
|
169,476
|
|
|
$
|
229,479
|
|
Net cash provided by (used in) investing activities
|
43,883
|
|
|
(96,209
|
)
|
||
Net cash used in financing activities
|
(185,185
|
)
|
|
(428,189
|
)
|
||
Net (decrease) increase in cash and cash equivalents
|
$
|
28,174
|
|
|
$
|
(294,919
|
)
|
|
Issuer Repurchases of Equity Securities
|
||||||||||||
|
(in thousands, except per share amounts)
|
||||||||||||
|
Total Number
of Shares Purchased |
|
Average Price
Paid
per Share
|
|
Total Number of
Shares Purchased as Part of
Publicly Announced
Plans or Programs |
|
Maximum Amount
That May Yet
Be Purchased
Under the Plans
or Programs
|
||||||
Sep. 27, 2009 - Oct. 24, 2009
|
810
|
|
|
$
|
18.10
|
|
|
810
|
|
|
$
|
483,451
|
|
Oct. 25, 2009 - Nov. 21, 2009
|
960
|
|
|
17.74
|
|
|
960
|
|
|
466,417
|
|
||
Nov. 22, 2009 - Dec. 26, 2009
|
825
|
|
|
18.43
|
|
|
825
|
|
|
451,209
|
|
||
Total for the quarter
|
2,595
|
|
|
$
|
18.07
|
|
|
2,595
|
|
|
$
|
451,209
|
|
Nominee
|
|
Votes in Favor
|
|
Votes Withheld
|
||
B. Kipling Hagopian
|
|
180,527,603
|
|
|
101,648,100
|
|
Tunc Doluca
|
|
226,257,301
|
|
|
55,818,402
|
|
James R. Bergman
|
|
150,815,264
|
|
|
131,360,439
|
|
Joseph R. Bronson
|
|
225,616,246
|
|
|
56,559,458
|
|
Robert E. Grady
|
|
154,049,107
|
|
|
128,126,596
|
|
William D. Watkins
|
|
222,301,746
|
|
|
59,873,957
|
|
A.R. Frank Wazzan
|
|
166,375,156
|
|
|
115,800,547
|
|
31.1
|
|
Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
31.2
|
|
Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
32.1
|
|
Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
32.2
|
|
Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
Date: February 4, 2010
|
MAXIM INTEGRATED PRODUCTS, INC.
|
|
By:
|
/s/ Bruce E. Kiddoo
Senior Vice President,
Chief Financial Officer and
Principal Accounting Officer
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|
No information found
Customers
Customer name | Ticker |
---|---|
IES Holdings, Inc. | IESC |
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|